본문 바로가기
KERD
논문KCI 등재

우울증의 진단 및 평가 지침 개발 : 진단 지침을 중심으로

Development of Clinical Guideline for the Diagnosis and Evaluation of Depression : Focused on Diagnosis Guideline

구본훈|조현주|김민경|사공정규|성형모|이준엽|김대현|김정범|김양태|정성원|신임희|문은수|최정식|정인명
대한신경정신의학회 (Korean Neuropsychiatric Association)|2014.01|신경정신의학 (JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION)|제53권 제1호|pp. 15-23

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

평가EvaluationDepression우울장애우울증진단DiagnosisClinical practice guideline임상진료지침Depressive disorder
주제분류정신과학

초록

진단율을 향상시키기 위한 방법에 대한 근거는 부족하므로 이에 대한 연구가 향후 이루어질 필요가 있으며, PHQ-9나 PHQ-2와 같은 진단선별 도구들은 진단과정에서 유용성이 입증되어 있으므로 임상 실제에서 적절하게 사용하는 것이 좋겠다.

Abstract

Objectives The aim of this study is to develop guideline for use in diagnosis of depression. Methods Development of this guideline was processed according to the ADAPTE manual,which was developed for adaptation of good clinical practice guidelines. Important key questionswere determined, and a systematic review of clinical practice guidelines was performed. Thecontents of guidelines selected by comparison of the methodological quality and currency wereevaluated with regard to the applicability and acceptability. Answers to key questions and clinicalrecommendations were established by peer review. Results There has been no evidence on strategies to improve the accuracy and rate of diagnosisof depression. The screening tools for depression were useful in diagnosis of depression inclinical practice. Conclusion The results of this study may suggest the necessity of strategies to improve thevalidity and reliability of diagnosis of depression. In contrast, scales for screening depression canbe useful in diagnosis of depression. This guideline did not include systematic reviews regardinguseful scales for diagnosis of depression. In the future, amendment of this guideline might beneeded in order to supplement limitations.

참고문헌 (51)

  1. Mental Health: New Understanding, New Hope, "World Health Organization", The World Health Report, ~ (2001)
  2. Patten SB, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management", J Affect Disord, 117(1), pp.S5~S14 (2009)
  3. Cho MJ, "The Epidemiology Survey of Mental Disorders in Korea" (2011), Ministry of Health and Welfare
  4. clinical psychiatry, "Kaplan & Sadock’s synopsis of psychiatry: behavioral sciences", pp.2007, Sadock BJ
  5. American Psychiatric Association, "Text revision (DSM-IV-TR)" (2000), American Psychiatric Association
  6. World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines", WHO, ~ (1993)
  7. Ereshefsky L., "The Texas Medication Algorithm Project for major depression", Manag Care, 10(8), pp.16~17 (2001)
  8. Hyler SE., "APA Online CME Practice Guideline for the Treatment of Patients with Major Depressive Disorder", J Psychiatr Pract, 8, pp.315~319 (2002)
  9. Anderson IM, "Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines", J Psychopharmacol, 22, pp.343~396 (2008)
  10. Lam RW, "Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy", J Affect Disord, 117(Suppl 1), pp.S26~S43 (2009)
  11. Poses RM., "Efficacy of antidepressants and USPSTF guidelines for depression screening", Ann Intern Med, 152, pp.753~ (2010)
  12. Depression:the Treatment and Management of Depression in Adults, "National Institute for Health and Clinical Excellence", National Institute for Health and Clinical Excellence, ~ (2009)
  13. Kim SY, "Manual for Guideline Adaptation Ver 2.0" (2011), National Evidence-based Healthcare Collaborating Agency
  14. ICSI Health Care Guideline Working Group, "Institude for Clinical System Improvement (ICSI) Health Care Guideline: Major Depression in Adults in Primary Care" (2011), Institute for Clinical Systems Improvement, Inc
  15. Kennedy SH, "Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies", J Affect Disord, 117(Suppl 1), pp.S44~S53 (2009)
  16. New Zealand Guidelines Group, "Identification of Common Mental Disorders and Management of Depression in Primary Care: Best practice evidence-based guideline", New Zealand Guidelines Group, ~ (2008)
  17. Gilbody S, "Screening for depression in medical settings with the Patient Health Questionnaire (PHQ):a diagnostic meta-analysis", J Gen Intern Med, 22, pp.1596~1602 (2007)
  18. Kroenke K, "The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review", Gen Hosp Psychiatry, 32, pp.345~359 (2010)
  19. Wittkampf KA, "Diagnostic accuracy of the mood module of the Patient Health Questionnaire:a systematic review", Gen Hosp Psychiatry, 29, pp.388~395 (2007)
  20. Kroenke K, "The PHQ-9: validity of a brief depression severity measure", J Gen Intern Med, 16, pp.606~613 (2001)
  21. Löwe B, "Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses", J Affect Disord, 78, pp.131~140 (2004)
  22. Wulsin L, "The Feasibility of Using the Spanish PHQ-9 to Screen for Depression in Primary Care in Honduras", Prim Care Companion J Clin Psychiatry, 4, pp.191~195 (2002)
  23. Henkel V, "Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups", Gen Hosp Psychiatry, 26, pp.190~198 (2004)
  24. Eack SM, "Limitations of the Patient Health Questionnaire in identifying anxiety and depression in community mental health: many cases are undetected", Res Soc Work Pract, 16, pp.625~631 (2006)
  25. Adewuya AO, "Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students", J Affect Disord, 96, pp.89~93 (2006)
  26. Gilbody S, "Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9and CORE-OM", Br J Gen Pract, 57, pp.650~652 (2007)
  27. McManus D, "Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study)", Am J Cardiol, 96, pp.1076~1081 (2005)
  28. Watnick S, "Validation of 2 depression screening tools in dialysis patients", Am J Kidney Dis, 46, pp.919~924 (2005)
  29. Persoons P, "Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIMEMD Patient Health Questionnaire and epidemiology", Gen Hosp Psychiatry, 25, pp.316~323 (2003)
  30. Fann JR, "Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury", J Head Trauma Rehabil, 20, pp.501~511 (2005)
  31. Williams LS, "Performance of the PHQ-9 as a screening tool for depression after stroke", Stroke, 36, pp.635~638 (2005)
  32. Picardi A, "Screening for depressive disorders in patients with skin diseases: a comparison of three screeners", Acta Derm Venereol, 85, pp.414~419 (2005)
  33. Diez-Quevedo C, "Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients", Psychosom Med, 63, pp.679~686 (2001)
  34. Kroenke K, "The Patient Health Questionnaire-2: validity of a two-item depression screener", Med Care, 41, pp.1284~1292 (2003)
  35. Löwe B, "Detecting and monitoring depression with a two-item questionnaire (PHQ-2)", J Psychosom Res, 58, pp.163~171 (2005)
  36. Spitzer RL, "Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire", JAMA, 282, pp.1737~1744 (1999)
  37. Pinto-Meza A, "Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone?", J Gen Intern Med, 20, pp.738~742 (2005)
  38. Löwe B, "Monitoring depression treatment outcomes with the patient health questionnaire-9", Med Care, 42, pp.1194~1201 (2004)
  39. Duffy FF, "Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry?", Psychiatr Serv, 59, pp.1148~1154 (2008)
  40. Huang FY, "Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients", J Gen Intern Med, 21, pp.547~552 (2006)
  41. Yeung A, "Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans", Compr Psychiatry, 49, pp.211~217 (2008)
  42. Lotrakul M, "Reliability and validity of the Thai version of the PHQ-9", BMC Psychiatry, 8, pp.46~ (2008)
  43. Han C, "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population:the Ansan Geriatric study", Compr Psychiatry, 49, pp.218~223 (2008)
  44. Donnelly PL, "The Patient Health Questionnaire (PHQ-9K)to screen for depressive disorders among immigrant Korean American elderly", J Cult Divers, 15, pp.24~29 (2008)
  45. 안제용, "한국어판 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)의 표준화 연구", 생물치료정신의학, 19(1), pp.47~56 (2013), 대한생물치료정신의학회
  46. 신재현, "한글판 우울증 선별 도구 (Patient Health Qustionnaire-2)의 표준화 연구", 신경정신의학, 52(3), pp.115~121 (2013), 대한신경정신의학회
  47. U.S. Preventive Services Task Force, "Screening for depression. Systematic Evidence Review", US Preventive Services Task Force, ~ (2002)
  48. Arroll B, "Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population", Ann Fam Med, 8, pp.348~353 (2010)
  49. Zimmerman M, "The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity", Compr Psychiatry, 42, pp.175~189 (2001)
  50. Spitzer RL, "The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description", Arch Gen Psychiatry, 49, pp.624~629 (1992)
  51. Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.):the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(20), pp.22~33 (1998)

관련 논문AI추천

우울증의 진단 및 평가 지침 개발 : 평가 지침을 중심으로구본훈, 김대현, 김민경, 김양태, 김정범, 문은수, 성형모, 신임희, 이준엽, 정성원, 정인명, 조현주, 최정식, 사공정규대한신경정신의학회 · 신경정신의학2014 · 제53권 제1호우울증 관련 평가도구의 개관전태연, 조현주, 채정호대한신경정신의학회 · 신경정신의학2007 · 제46권 제2호국내 우울증 평가도구 타당화 연구의 체계적 고찰-진단적 타당성을 중점으로 : 한국형 우울 선별 도구 개발을 위한 예비 연구김신향, 박기호, 이승환, 이원혜, 정수연, 최기홍, 최윤영, 제갈은주대한불안의학회 · 대한불안의학회지2017 · 제13권 제2호한국형 우울장애 선별도구의 개발: 예비연구김신향, 박기호, 이승환, 이원혜, 정수연, 최기홍, 최윤영, 제갈은주한국임상심리학회 · Korean Journal of Clinical Psychology2017 · 제36권 제4호한국형 우울장애 선별도구 개발과정: 예비 타당화 연구김신향, 김초롱, 박기호, 박연수, 백승연, 윤서원, 이빛나, 이승환, 이원혜, 정수연, 최기홍, 최윤영한국임상심리학회 · Korean Journal of Clinical Psychology2018 · 제37권 제2호한국어판 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)의 표준화 연구김정범, 서은란, 신재현, 안제용, 임경희대한생물치료정신의학회 · 생물치료정신의학2013 · 제19권 제1호

이 간행물의 다른 논문 (6건)

번개탄을 이용한 자살에 대한 전반적 고찰과 예방 대책이아롱, 홍진표, 안명희, 이태엽, 정수연pp. 1-7학교기반 자살예방 프로그램 : 장점과 제한에 대한 교사의 인식권용실, 권호인, 노법래, 김란, 서은희, 홍현주pp. 8-14우울증의 진단 및 평가 지침 개발 : 평가 지침을 중심으로성형모, 사공정규, 김민경, 조현주, 구본훈, 정성원, 신임희, 문은수, 최정식, 정인명, 이준엽, 김대현, 김정범, 김양태pp. 24-31정신질환자의 인권지표 개발 : 국립병원의 조현병과 양극성장애 환자를 중심으로시영화, 홍창희, 배안, 정성미, 윤보현pp. 32-39집단음악치료가 통원치료 중인 조현병 환자의 사회적 기능과 대인관계에 미치는 영향박민철, 이대보, 이상열, 이혜진pp. 40-53
원문 보기